Literature DB >> 29773591

t(11;14)-positive mantle cell lymphomas lacking cyclin D1 (CCND1) immunostaining because of a CCND1 mutation or exclusive expression of the CCND1b isoform.

Ingram Iaccarino1,2, Lamis Afify3, Sietse M Aukema3, Katharina Reddemann3, Philipp Schütt4, Martin Flür5, Wolfram Klapper3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29773591      PMCID： PMC6119140          DOI： 10.3324/haematol.2018.192435

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  13 in total

1.  The relative levels of cyclin D1a and D1b alternative transcripts in mantle cell lymphoma may depend more on sample origin than on CCND1 polymorphism.

Authors:  Nathalie Carrère; Marc-Antoine Belaud-Rotureau; Pierre Dubus; Marie Parrens; Antoine de Mascarel; Jean-Philippe Merlio
Journal:  Haematologica       Date:  2005-06       Impact factor: 9.941

2.  Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma.

Authors:  A B Gladden; R Woolery; P Aggarwal; M A Wasik; J A Diehl
Journal:  Oncogene       Date:  2006-02-16       Impact factor: 9.867

3.  Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity.

Authors:  Michal Marzec; Monika Kasprzycka; Raymond Lai; Andrew B Gladden; Pawel Wlodarski; Ewa Tomczak; Peter Nowell; Samuel E Deprimo; Seth Sadis; Stephen Eck; Stephen J Schuster; J Alan Diehl; Mariusz A Wasik
Journal:  Blood       Date:  2006-05-11       Impact factor: 22.113

4.  Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation.

Authors:  J R Alt; J L Cleveland; M Hannink; J A Diehl
Journal:  Genes Dev       Date:  2000-12-15       Impact factor: 11.361

Review 5.  Histopathology of mantle cell lymphoma.

Authors:  Wolfram Klapper
Journal:  Semin Hematol       Date:  2011-07       Impact factor: 3.851

6.  Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation.

Authors:  David A Solomon; Ying Wang; Sejal R Fox; Tah C Lambeck; Sarah Giesting; Zhengdao Lan; Adrian M Senderowicz; Claudio J Conti; Erik S Knudsen
Journal:  J Biol Chem       Date:  2003-05-12       Impact factor: 5.157

7.  Cyclin D1 harboring the T286I mutation promotes oncogenic activation in endometrial cancer.

Authors:  Yuji Ikeda; Katsutoshi Oda; Osamu Hiraike-Wada; Takahiro Koso; Aki Miyasaka; Tomoko Kashiyama; Michihiro Tanikawa; Kenbun Sone; Kazunori Nagasaka; Daichi Maeda; Kei Kawana; Shunsuke Nakagawa; Masashi Fukayama; Osamu Tetsu; Tomoyuki Fujii; Tetsu Yano; Shiro Kozuma
Journal:  Oncol Rep       Date:  2013-06-03       Impact factor: 3.906

Review 8.  Cyclin D1: polymorphism, aberrant splicing and cancer risk.

Authors:  K E Knudsen; J Alan Diehl; C A Haiman; E S Knudsen
Journal:  Oncogene       Date:  2006-03-13       Impact factor: 9.867

9.  Alternate splicing produces a novel cyclin D1 transcript.

Authors:  D C Betticher; N Thatcher; H J Altermatt; P Hoban; W D Ryder; J Heighway
Journal:  Oncogene       Date:  1995-09-07       Impact factor: 9.867

10.  Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma.

Authors:  Marios Giannakis; Xinmeng Jasmine Mu; Sachet A Shukla; Zhi Rong Qian; Ofir Cohen; Reiko Nishihara; Samira Bahl; Yin Cao; Ali Amin-Mansour; Mai Yamauchi; Yasutaka Sukawa; Chip Stewart; Mara Rosenberg; Kosuke Mima; Kentaro Inamura; Katsuhiko Nosho; Jonathan A Nowak; Michael S Lawrence; Edward L Giovannucci; Andrew T Chan; Kimmie Ng; Jeffrey A Meyerhardt; Eliezer M Van Allen; Gad Getz; Stacey B Gabriel; Eric S Lander; Catherine J Wu; Charles S Fuchs; Shuji Ogino; Levi A Garraway
Journal:  Cell Rep       Date:  2016-04-14       Impact factor: 9.423
View more
  5 in total

Review 1.  Molecular Pathogenesis of Mantle Cell Lymphoma.

Authors:  Alba Navarro; Sílvia Beà; Pedro Jares; Elías Campo
Journal:  Hematol Oncol Clin North Am       Date:  2020-07-22       Impact factor: 3.722

2.  Truncation of 3' CCND1 by t(11;22) leads to negative SP4 CCND1 immunohistochemistry in blastoid mantle cell lymphoma.

Authors:  Fumiyo Maekawa; Chiyuki Kishimori; Miho Nakagawa; Kayo Takeoka; Katsuhiro Fukutsuka; Masahiko Hayashida; Futoshi Iioka; Masakazu Fujimoto; Kengo Takeuchi; Hirokazu Nakamine; Hitoshi Ohno
Journal:  Blood Adv       Date:  2021-01-12

3.  ISG20 serves as a potential biomarker and drives tumor progression in clear cell renal cell carcinoma.

Authors:  Tianbo Xu; Hailong Ruan; Su Gao; Jingchong Liu; Yuenan Liu; Zhengshuai Song; Qi Cao; Keshan Wang; Lin Bao; Di Liu; Junwei Tong; Jian Shi; Huageng Liang; Hongmei Yang; Ke Chen; Xiaoping Zhang
Journal:  Aging (Albany NY)       Date:  2020-01-30       Impact factor: 5.682

Review 4.  Current Knowledge in Genetics, Molecular Diagnostic Tools, and Treatments for Mantle Cell Lymphomas.

Authors:  Shenon Sethi; Zachary Epstein-Peterson; Anita Kumar; Caleb Ho
Journal:  Front Oncol       Date:  2021-11-23       Impact factor: 6.244

Review 5.  The pathologic diagnosis of mantle cell lymphoma.

Authors:  Shaoying Li; Jie Xu; M James You
Journal:  Histol Histopathol       Date:  2021-06-11       Impact factor: 2.303
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.